Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.065
-0.205 (-16.13%)
Jan 22, 2025, 9:55 AM EST - Market open
DRMA's stock price has decreased by -78.89% in the past year and price targets may not have had time to catch up.
Dermata Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$6.00
Upside
+463.27%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $10 → $6 | Strong Buy | Maintains | $10 → $6 | +463.27% | Aug 21, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $240 → $60 | Strong Buy | Maintains | $240 → $60 | +5,532.75% | Mar 23, 2023 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $3,360 | Strong Buy | Initiates | $3,360 | +315,333.72% | Sep 21, 2021 |
| Maxim Group | Maxim Group | Strong Buy Initiates $2,160 | Strong Buy | Initiates | $2,160 | +202,678.82% | Sep 14, 2021 |